Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

GBT Insider Trading

GBT | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at GBT provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2018-02-03 04:17 2018-02-01 Radovich Peter Officer - See Remarks OPT+S $57.30 812 $46,528 6,817 0.0%
2018-01-26 04:09 2018-01-23 Radovich Peter Officer - See Remarks OPT+S $60.00 30,000 $1,800,000 3,581 0.0%
2018-01-19 03:59 2018-01-17 Choi Jung Officer - See Remarks OPT+S $52.85 3,000 $158,550 134,778 0.0%
2018-01-12 05:48 2018-01-10 Radovich Peter Officer - See Remarks OPT+S $50.00 15,000 $750,000 2,684 0.0%
2017-12-21 01:12 2017-12-18 Choi Jung Officer - See Remarks OPT+S $36.55 3,000 $109,650 135,255 0.0%
2017-12-20 04:22 2017-12-19 PERCEPTIVE ADVISORS LLC 10% owner BUY $38.00 175,000 $6,650,000 4,889,066 +3.7%
2017-11-22 00:30 2017-11-17 Choi Jung Officer - See Remarks OPT+S $39.75 3,000 $119,250 136,855 0.0%
2017-11-01 03:15 2017-10-30 Radovich Peter Officer - Senior VP, Operations SELL $35.00 12,500 $437,500 0 -100.0%
2017-10-28 00:15 2017-10-26 HOMCY CHARLES J Director SELL $33.97 70,000 $2,377,550 67,728 -50.8%
2017-10-19 01:19 2017-10-17 Choi Jung Officer - See Remarks OPT+S $32.65 3,000 $97,950 138,455 0.0%
2017-10-06 00:00 2017-10-03 HOMCY CHARLES J Director SELL $0.00 0 $0 0 -100.0%
2017-10-03 00:27 2017-09-29 Choi Jung Officer - See Remarks OPT+S $30.00 3,000 $90,000 140,055 0.0%
2017-09-06 01:37 2017-08-31 Radovich Peter Officer - See Remarks SELL $30.00 2,410 $72,300 2,684 -47.3%
2017-09-06 01:36 2017-08-31 Choi Jung Officer - See Remarks OPT+S $30.00 3,000 $90,000 141,655 0.0%
2017-07-28 00:49 2017-07-25 PATRICK DEVAL L Director OPT+S $29.69 27,053 $803,204 0 0.0%
2017-07-26 02:02 2017-07-21 Choi Jung Officer - See Remarks OPT+S $30.00 3,000 $90,000 143,255 0.0%
2017-06-23 04:38 2017-06-01 HOMCY CHARLES J Director SELL $27.08 100,000 $2,708,470 137,728 -42.1%
2017-04-11 00:30 2017-04-06 TEPPER ROBERT I 10% owner SELL $33.23 31,225 $1,037,576 229,773 -12.0%
2017-03-07 03:49 2017-03-02 HOMCY CHARLES J Director SELL $0.00 0 $0 0 -100.0%
2017-03-07 03:47 2017-03-02 Third Rock Ventures II, L.P. 10% owner SELL $25.54 2,045,294 $52,245,399 146,208 -93.3%
2016-12-21 01:46 2016-12-16 STARR KEVIN P 10% owner SELL $16.00 108,955 $1,743,345 82,544 -56.9%
2016-11-17 00:10 2016-11-14 HOMCY CHARLES J Director SELL $0.00 0 $0 0 -100.0%
2016-11-17 00:12 2016-11-14 Third Rock Ventures II, L.P. 10% owner SELL $19.36 2,000,000 $38,720,000 1,285,713 -60.9%
2016-03-15 01:20 2015-08-17 Choi Jung Officer - See Remarks BUY $20.00 25,000 $500,000 25,000 +100.0%
2016-01-08 05:39 2015-08-17 Choi Jung Officer - See Remarks BUY $20.00 25,000 $500,000 167,857 +17.5%
2016-01-08 05:34 2015-08-17 Sham Hing Officer - SVP of Chemistry BUY $20.00 2,000 $40,000 36,775 +5.8%
2016-01-08 05:29 2015-08-17 Radovich Peter Officer - See Remarks BUY $20.00 12,500 $250,000 12,500 +100.0%
2016-01-08 05:28 2015-08-17 Ramos Eleanor Officer - Chief Medical Officer BUY $20.86 12,000 $250,280 1,000 +100.0%
2016-01-08 05:55 2015-08-17 Schembri John Officer - See Remarks BUY $21.57 1,500 $32,360 1,500 +100.0%
2016-01-08 05:43 2015-08-17 PERRY MARK L Director BUY $20.00 5,000 $100,000 26,428 +23.3%
2016-01-08 05:39 2015-08-17 LOVE TED W Director, Officer - See Remarks BUY $20.00 10,000 $200,000 2,500 +100.0%
2016-01-08 05:41 2015-08-17 PATRICK DEVAL L Director BUY $20.00 2,500 $50,000 2,500 +100.0%
2015-12-24 04:39 2015-08-17 Ramos Eleanor Officer - Chief Medical Officer BUY $20.93 11,000 $230,280 11,000 +100.0%
SHOW ENTRIES

How to Interpret $GBT Trades

Not every insider transaction in GBT is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $GBT shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for GBT

Insider activity data for GBT is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $GBT, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.